| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |